Although it has classically been considered that HLA-G expression is restricted to the maternal-fetal interface, the thymus, and the cornea, several recent studies have found increased levels of HLA-G in the plasma87–89 and in GVHD target organs in patients receiving allogeneic HCTs87. Here, HLA-G is linked to graft versus host disease.